Endologix Inc. (ELGX) Soars 7.9% on December 28

Endologix Inc. (ELGX) had a good day on the market for Friday December 28 as shares jumped 7.9% to close at $0.74. About 814,538 shares traded hands on 3,648 trades for the day, compared with an average daily volume of n/a shares out of a total float of 103.45 million. After opening the trading day at $0.70, shares of Endologix Inc. stayed within a range of $0.74 to $0.69.

With today’s gains, Endologix Inc. now has a market cap of $77.02 million. Shares of Endologix Inc. have been trading within a range of $6.72 and $0.60 over the last year, and it had a 50-day SMA of $n/a and a 200-day SMA of $n/a.

Endologix Inc develops, manufacture, market, and sell innovative medical devices for the treatment of aortic disorders in the United States and internationally. It product Includes a variety of endovascular stent grafts for the treatment of abdominal aortic aneurysms such as AFX Endovascular AAA System, VELA Proximal Endograft, and Ovation Abdominal Stent Graft System. The firm generates the majority of its revenue in the United States.

Endologix Inc. is based out of Irvine, CA and has some 675 employees. Its CEO is John Onopchenko.